{"symbol":"REGN","fiscalQuarter":"Q1-2011","reportDate":"2011-05-03","reportTime":"BMO","status":"reported","company":{"name":"Regeneron Pharmaceuticals, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/REGN/earnings/Q1-2011","postBrief":{"headline":"Regeneron Pharmaceuticals Misses on EPS, Stock Down 4.84%","keyNumbers":[{"metric":"EPS","actual":"$-0.49","expected":"N/A","surprise":"-27.94%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management acknowledged the challenges faced this quarter.","They emphasized a focus on long-term growth despite current setbacks."],"summary":"Management expressed concerns about recent performance but remains committed to future strategies. They did not provide specific guidance for upcoming quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"This earnings report indicates that Regeneron Pharmaceuticals faced challenges this quarter, particularly reflected in the negative EPS. The stock dropped 4.84% in reaction to the disappointing earnings, signaling investor concern. Without guidance, uncertainty remains about the company's near-term performance and strategy.","metaDescription":"Regeneron Pharmaceuticals (REGN) Q1 2011 earnings: EPS missed. Stock down 4.84%. Full breakdown."}}